Continuous Renal Replacement Therapy Market – By Modality (Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Slow Continuous Ultrafiltration), By Product (Instruments, Consumables), By Therapy, & Forecast, 2023 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationContinuous Renal Replacement Therapy Market Size
Continuous Renal Replacement Therapy Market size was worth more than USD 1 billion in 2022 and is estimated to witness robust growth at 6.9% CAGR from 2023 to 2032 attributed to the rising incidences of chronic renal diseases. As per recent data from 2022, chronic kidney diseases (CKD) is projected to impact 9.1% to 13.4% of the global population.
The growing episodes of kidney disorders can be attributed to unhealthy lifestyles as well as the increasing prevalence of diabetes, hypertension, and other comorbidities. According to the CDC, 37.3 million Americans, or 11.3% of the population suffered from diabetes in 2022. Furthermore, the presence of rapidly expanding geriatric population base worldwide vulnerable to renal illnesses has surged the demand for CRRT treatments. Moreover, the rising demand for advanced CRRT equipment and procedures in clinical settings to offer higher effectiveness, safety, and convenience of use will add to the market expansion.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Continuous Renal Replacement Therapy Market Size in 2022 | USD 1.1 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 6.9% |
| 2032 Value Projection | USD 2.2 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 160 |
| Tables, Charts & Figures | 361 |
| Segments covered | Modality, Product, Therapy, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
The operational challenges associated with CRRT treatment methods may pose as a restraint for the market growth. To operate and manage the equipment efficiently, CRRT requires specialized training and technical knowledge. Increasing errors in machine setup, parameter modifications, or patient management leading to complications along with the shortage of qualified workers may also slow down the market growth.
COVID-19 Impact
The COVID-19 outbreak imposed unexpected challenges for patients with renal diseases and their care providers. The pandemic disrupted global supply chains, impacting the availability of medical equipment such as CRRT machines and consumables. However, it had favorable influence on the overall market. According to studies, more than 30% of COVID-19 hospitalized patients experienced renal injury, and more than 50% of patients in ICUs with kidney injury required dialysis. Nevertheless, the need to identify effective COVID-19 therapies stimulated medical research and innovation, adding to the market progression.
Continuous Renal Replacement Therapy Market Trends
Hey there! Exciting things are happening in the world of kidney treatment! Machines that help clean the blood of people with kidney problems (called CRRT systems) are getting a serious upgrade. These new systems are way easier to use, thanks to fancy touchscreens and features that adjust themselves based on the patient. Plus, they're safer, with alerts that warn if anything's going wrong. Hospitals are loving these newfangled machines because they make setting up treatments a breeze, keep everything running smoothly, and reduce the risk of mistakes. For example, a hospital called Peconic Bay Medical Centre just launched a whole new program using these CRRT machines for people with kidney issues. They're super excited about it!
Continuous Renal Replacement Therapy Market Analysis
Continuous renal replacement therapy market size from the continuous venovenous hemodialysis (CVVHD) is expected to reach USD 1 billion by 2032. CVVH is an effective and adaptable therapy for critically ill AKI (acute kidney injury) patients as it offers continuous renal support, offering more progressive and continuous filtration of patients' blood flow. It is useful for a wide spectrum of AKI patients due to its capacity to adjust therapy to specific patient demands. Widespread acceptability and significant adoption across critical care settings will fuel the segment expansion.
In 2022, the medical supplies used in a special treatment for kidney failure, called continuous renal replacement therapy (CRRT), were a big chunk of the market. And, get this, they're expected to grow like crazy, reaching about $1.3 billion by 2032! Two key components of CRRT are hemofilters and dialyzers. They're like tiny filters that help clean out waste products, extra fluids, and salts from the blood. These fancy filters have gotten so good at their job that CRRT is now more effective, helping patients feel better. Governments are also stepping in to help with these treatments. For example, in India, the government's special program for dialysis has already helped a lot of peopleas of December 2022, it had provided dialysis for a whopping 1.7 million patients!
North America continuous renal replacement therapy market size exceeded USD 371 million in 2022 and will record substantial growth through 2032 owing to the increasing demand for CRRT among the expanding senior population prone to renal failures. According to NIDDK estimates, the incidence of CKD in those aged 65 and more in the U.S. is 14%, meaning that approximately 1 in every 7 adults aged 65 and more have CKD. Furthermore, the rising per capita incomes and healthcare spending will have beneficial impact on the regional market outlook.
Continuous Renal Replacement Therapy Market Share
Some of the key players operating in the continuous renal replacement therapy market include
- Medtronic
- B.Braun Melsungen
- Asahi Kasei Corporation
- Baxter International Inc.
- Medica
- Medites
- Medical Components
- Nikkiso
- Nxtstage
- Toray
- Tricol Biomedical
Continuous Renal Replacement Therapy Industry News
- In May 2022, Baxter International Inc., announced that its ST Set for continuous renal replacement therapy (CRRT) received FDA 510(k) approval.
- In August 2022, Fresenius Medical Care North America's Renal Therapies Group launched Speedswap®, as a new option for the NxStage® System OneTM with NxViewTM to allow the replacement of a flow-compromised dialysis filter without replacing the complete cartridge.
Continuous renal replacement therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) and volume (Units) from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Modality, 2018 - 2032 (USD Million)
- Continuous Venovenous Hemofiltration
- Continuous Venovenous Hemodiafiltration
- Continuous Venovenous Hemodialysis
- Slow Continuous Ultrafiltration
By Product, 2018 - 2032 (USD Million & Units)
- Instruments
- Consumables
By Therapy, 2018 - 2032 (USD Million)
- Renal
- Non-renal
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Switzerland
- The Netherlands
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Indonesia
- Philippines
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Colombia
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Iran
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy